Your browser doesn't support javascript.
loading
MicroRNA-26a-5p as a potential predictive factor for determining the effectiveness of trastuzumab therapy in HER-2 positive breast cancer patients.
Tehrani, Sadra Samavarchi; Zaboli, Ehsan; Sadeghi, Farzin; Khafri, Soraya; Karimian, Ansar; Rafie, Mahnoosh; Parsian, Hadi.
Afiliação
  • Tehrani SS; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Zaboli E; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
  • Sadeghi F; Gastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
  • Khafri S; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
  • Karimian A; Department of Epidemiology, Babol University of Medical Sciences, Babol, Iran.
  • Rafie M; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • Parsian H; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Biomedicine (Taipei) ; 11(2): 30-39, 2021.
Article em En | MEDLINE | ID: mdl-35223402
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicine (Taipei) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã País de publicação:
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biomedicine (Taipei) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irã País de publicação: